EN

European Neuropsychopharmacology

European Neuropsychopharmacology is the official journal of the European College of Neuropsychopharmacology and focuses on clinical and basic science contributions that advance understanding of brain function and human behaviour, with emphasis on translating neuroscience and genomics findings into improved psychiatric treatments and public health impact.

Looking to publish in European Neuropsychopharmacology? Livewrite integrates seamlessly with Word to help you write, edit, and format faster.

Existing customer login
Impact Factor 6.7
Quartile Q1
Open Access Type Hybrid
ISSN 0924-977X
eISSN 1873-7862
Invitation Only No
Cost Range Article Publishing Charge: USD 3000 excl. taxes for all articles published open access; no open access publication fee for subscription articles.

Submission Instructions

European Neuropsychopharmacology accepts the following article types. Click on an article type to view submission instructions.

Full Length Research Papers

Cover Letter A covering letter must accompany the submission.
Abstract An abstract is required. Abstract must be a single paragraph of no more than 250 words. Abstract must be unstructured as a single paragraph.
Manuscript Full Length Research Papers must not exceed 6500 words including tables and figure legends. Text must be organized under the headings Introduction, Experimental procedures, Results, Discussion, Author Disclosures, and References. Manuscript must include 3 to 6 Index Medicus keywords, and highlights are optional but if submitted must be provided in a separate file with 3 to 5 bullet points of no more than 85 characters each.
References Full Length Research Papers must contain no more than 80 references. References must include only published articles and articles in press, with in-text citations using author name and year and the reference list arranged alphabetically and then chronologically when needed.
Figures & Tables Figures and photographs must be submitted as separate files, and each table must be uploaded separately on its own page. A legend is required for every figure or photograph, and tables must be numbered consecutively, cited in sequence, and include a brief complete title with explanatory footnotes as needed.
Reformat to European Neuropsychopharmacology using Livewrite Premium

Reviews On Specialised Topics

Cover Letter A covering letter must accompany the submission.
Abstract An abstract is required. Abstract must be a single paragraph of no more than 250 words. Abstract must be unstructured and presented as a single paragraph.
Manuscript There is no word limit for Reviews On Specialised Topics. Text must be ordered under the headings Introduction, Experimental procedures, Results, Discussion, Author Disclosures, and References. The manuscript must include 3 to 6 Index Medicus keywords, while highlights are optional and if submitted must be provided in a separate file with 3 to 5 bullet points of no more than 85 characters each.
References Reviews On Specialised Topics must contain no more than 150 references. References must include only published articles and articles in press, use author-year citations in the text, and be arranged alphabetically and then chronologically with same-year works distinguished by letters.
Figures & Tables Figures and photographs must be submitted as separate files, and each table must be uploaded separately on its own page. Each figure or photograph must have a legend, and each table must be numbered consecutively, cited in sequence, and include a brief self-contained legend.
Reformat to European Neuropsychopharmacology using Livewrite Premium

Short Communications

Cover Letter A covering letter must accompany the submission.
Abstract An abstract is required. Abstract must be a single paragraph of no more than 250 words. Abstract must be unstructured as a single paragraph.
Manuscript Short Communications must be a maximum of 2500 words. Text must be ordered under the headings Introduction, Experimental procedures, Results, Discussion, Author Disclosures, and References. Manuscript must include 3 to 6 keywords taken from Index Medicus.
References Short Communications must contain no more than 25 references. References must be arranged alphabetically and then chronologically if needed, with in-text citations using author name and year.
Figures & Tables Figures and photographs must be submitted as separate files, and each table must be uploaded separately on its own page. Every figure or photograph must have a legend, and each table must have a brief complete title or legend and be numbered consecutively in Arabic numerals.
Reformat to European Neuropsychopharmacology using Livewrite Premium

Letters To The Editor

Cover Letter A covering letter must accompany the submission.
Abstract An abstract is required. Abstract must be no more than 250 words. Abstract must be presented as a single paragraph.
Manuscript Letters To The Editor are limited to 500 words. Text must be ordered under the headings Introduction, Experimental procedures, Results, Discussion, Author Disclosures, and References. The manuscript must include 3 to 6 Index Medicus keywords, while Highlights are optional and if submitted must be provided in a separate file with 3 to 5 bullet points of no more than 85 characters each.
References Letters To The Editor must contain no more than 5 references. References must be arranged alphabetically and then chronologically, and text citations must use author name-year formatting with 'et al.' for three or more authors.
Figures & Tables Figures and photographs must be submitted as separate files, and each table must be uploaded separately. Each figure or photograph must have a legend, and each table must be numbered consecutively and include a brief legend.
Reformat to European Neuropsychopharmacology using Livewrite Premium

Insights Papers

Cover Letter A covering letter must accompany the submission.
Abstract Abstract must not be included.
Manuscript Manuscript must be no more than 1000 words. Content should address a controversial topic. Manuscript must include a Declaration of Interest Statement.
References References must not exceed 10. References must be arranged alphabetically and then chronologically, and in-text citations use author-year format with 'et al.' for three or more authors.
Figures & Tables A maximum of 1 figure is permitted and tables must not be included. Figures must be submitted as separate files and each table, if any, must be uploaded separately. A legend must be provided for each figure.
Reformat to European Neuropsychopharmacology using Livewrite Premium

Recent Publications

Long-term outcomes of childhood ADHD stimulant use trajectories

Noa E. van der Plas, Siri D.S. Noordermeer, Catharina A. Hartman, Pieter J. Hoekstra, Nanda N.J. Rommelse, Emma Sprooten, Jaap Oosterlaan, Marjolein Luman

10.1016/j.euroneuro.2026.113861
View Publication

Erratum to “Long-term treatment with esketamine nasal spray in patients with treatment resistant depression: Results from the ESCAPE-LTE study” [European Neuropsychopharmacology 107 (2026) 112801]

A Reif, Yağcıoğlu AE Anıl, I Bitter, J Buyze, R Frey, DJ Fu, Y Godinov, L Haggström, Y Kambarov, RE Nielsen, AJ Oliveira-Maia, C von Holt, AH Young, WJ Cubała

10.1016/j.euroneuro.2026.113860
View Publication

Global patterns of clozapine prescribing: An international comparison of prescribing indications across 15 regions

Ita Fitzgerald, Sarah O’Dwyer, Ciara Ní Dhubhlaing, Siobhan Gee, Laura J. Sahm, Amanda Wheeler, Grainne Donohue, Veenu Gupta, Jo Howe, Christoph U Correll, Mikkel Højlund

10.1016/j.euroneuro.2026.113547
View Publication

Cognitive reserve beyond ageing and dementia: A framework for early psychosis prevention and intervention

Rosa Ayesa-Arriola, Elena de la Serna, Inmaculada Baeza, Israel Contador, Yaakov Stern

10.1016/j.euroneuro.2026.112919
View Publication

Corrigendum to “T70. Genetics of treatment resistant depression in Pakistan; update from the DIVERGE study” [European Neuropsychopharmacology 87, Supplement 1 (2024) 191]

Muhammad Umar, Arsalan Hassan, Fahad Hussain, Bakht Khizar, Inzemam Khan, Elvira Bramon, Glyn Lewis, Muhammad Ayub, Karoline Kuchenbaecker

10.1016/j.euroneuro.2026.112918
View Publication

Frequently asked questions

How long does it take to publish?

45 days from submission to decision after review; 33 days from submission to acceptance.

Reformat to European Neuropsychopharmacology using Livewrite Premium

Is a cover letter required?

A covering letter must accompany all submissions.

Reformat to European Neuropsychopharmacology using Livewrite Premium

What are the publication costs?

USD 3000 excl. taxes for open access articles; no open access publication fee for subscription articles.

Reformat to European Neuropsychopharmacology using Livewrite Premium

Research Topics

Schizophrenia research and treatment Treatment of Major Depression Bipolar Disorder and Treatment Tryptophan and brain disorders Neurotransmitter Receptor Influence on Behavior Neuroscience and Neuropharmacology Research Stress Responses and Cortisol Attention Deficit Hyperactivity Disorder Functional Brain Connectivity Studies Receptor Mechanisms and Signaling Diet and metabolism studies Mental Health Research Topics Electroconvulsive Therapy Studies Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes Child and Adolescent Psychosocial and Emotional Development Neuroendocrine regulation and behavior Obsessive-Compulsive Spectrum Disorders Autism Spectrum Disorder Research Neuropeptides and Animal Physiology Health, Environment, Cognitive Aging Epilepsy research and treatment Pharmacological Effects and Toxicity Studies Diverse Scientific and Economic Studies Genetics and Neurodevelopmental Disorders Genetic Associations and Epidemiology